or Try an Advanced Search...

    Technical Analysis for AWH - Aspira Women's Health Inc.

    Grade Last Price % Change Price Change
    F 0.99 -33.56% -0.50
    AWH closed down 33.56 percent on Monday, July 1, 2024, on 9.29 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical AWH trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Expansion Breakdown Bearish Swing Setup 0.00%
    Reversal New Lows Setup Bearish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Wide Range Bar Range Expansion 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Outside Day Range Expansion 0.00%
    Older End-of-Day Signals for AWH ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 5 hours ago
    Rose Above Previous Day's High about 5 hours ago
    10 DMA Resistance about 5 hours ago
    2x Volume Pace about 5 hours ago
    1.5x Volume Pace about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AWH Chart by TradingView
    Basic chart:

    Profile

    Aspira Women’s Health Inc. (formerly known as Vermillion, Inc. Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Patient Management Analytical Solutions Gynaecological Cancer Gynaecology

    Is AWH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 13 Aspira Women’s Health Provides Commercial, Reimbursement and Cash Guidance Updates
    May 16 Aspira Women’s Health to Present at the A.G.P. Healthcare Showcase on May 21
    May 8 UPDATE -- Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
    May 8 Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
    May 7 Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts
    Apr 9 Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
    Apr 5 Aspira Women's Health files to sell 1.57M shares for holders
    Mar 28 Aspira Women’s Health GAAP EPS of -$0.30 beats by $0.15, revenue of $2.13M misses by $0.42M
    Mar 28 Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript
    Mar 28 Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
    See more AWH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.75
    52 Week Low 0.8988
    Average Volume 85,381
    200-Day Moving Average 3.75
    50-Day Moving Average 2.45
    20-Day Moving Average 1.78
    10-Day Moving Average 1.47
    Average True Range 0.30
    RSI (14) 25.37
    ADX 44.64
    +DI 9.69
    -DI 29.88
    Chandelier Exit (Long, 3 ATRs) 1.64
    Chandelier Exit (Short, 3 ATRs) 1.79
    Upper Bollinger Bands 2.50
    Lower Bollinger Band 1.05
    Percent B (%b) -0.04
    BandWidth 81.91
    MACD Line -0.34
    MACD Signal Line -0.31
    MACD Histogram -0.0344
    Fundamentals Value
    Market Cap 10.23 Million
    Num Shares 10.3 Million
    EPS -1.66
    Price-to-Earnings (P/E) Ratio -0.60
    Price-to-Sales 5.42
    Price-to-Book 5.02
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.03
    Resistance 3 (R3) 2.11 1.85 1.85
    Resistance 2 (R2) 1.85 1.59 1.81 1.80
    Resistance 1 (R1) 1.42 1.42 1.29 1.34 1.74
    Pivot Point 1.16 1.16 1.09 1.12 1.16
    Support 1 (S1) 0.73 0.90 0.60 0.64 0.24
    Support 2 (S2) 0.47 0.73 0.43 0.18
    Support 3 (S3) 0.04 0.47 0.13
    Support 4 (S4) -0.05